Logo image of MDM.PA

MAISONS DU MONDE SA (MDM.PA) Stock Fundamental Analysis

EPA:MDM - Euronext Paris - Matif - FR0013153541 - Common Stock - Currency: EUR

2.765  -0.07 (-2.64%)

Fundamental Rating

3

Taking everything into account, MDM scores 3 out of 10 in our fundamental rating. MDM was compared to 50 industry peers in the Specialty Retail industry. MDM has a bad profitability rating. Also its financial health evaluation is rather negative. MDM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

MDM had negative earnings in the past year.
In the past year MDM had a positive cash flow from operations.
MDM had positive earnings in 4 of the past 5 years.
MDM had a positive operating cash flow in each of the past 5 years.
MDM.PA Yearly Net Income VS EBIT VS OCF VS FCFMDM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

With a Return On Assets value of -9.12%, MDM is not doing good in the industry: 72.00% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -27.98%, MDM is doing worse than 74.00% of the companies in the same industry.
Industry RankSector Rank
ROA -9.12%
ROE -27.98%
ROIC N/A
ROA(3y)-1.72%
ROA(5y)-0.18%
ROE(3y)-5.32%
ROE(5y)-0.76%
ROIC(3y)N/A
ROIC(5y)N/A
MDM.PA Yearly ROA, ROE, ROICMDM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

MDM has a better Gross Margin (65.80%) than 94.00% of its industry peers.
MDM's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for MDM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.25%
MDM.PA Yearly Profit, Operating, Gross MarginsMDM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

MDM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MDM remains at a similar level compared to 1 year ago.
The number of shares outstanding for MDM has been reduced compared to 5 years ago.
Compared to 1 year ago, MDM has a worse debt to assets ratio.
MDM.PA Yearly Shares OutstandingMDM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MDM.PA Yearly Total Debt VS Total AssetsMDM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

The Debt to FCF ratio of MDM is 4.88, which is a neutral value as it means it would take MDM, 4.88 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MDM (4.88) is comparable to the rest of the industry.
MDM has a Debt/Equity ratio of 0.93. This is a neutral value indicating MDM is somewhat dependend on debt financing.
MDM has a worse Debt to Equity ratio (0.93) than 72.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 4.88
Altman-Z N/A
ROIC/WACCN/A
WACC3.61%
MDM.PA Yearly LT Debt VS Equity VS FCFMDM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.72 indicates that MDM may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.72, MDM is doing worse than 88.00% of the companies in the same industry.
A Quick Ratio of 0.32 indicates that MDM may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.32, MDM is doing worse than 82.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.32
MDM.PA Yearly Current Assets VS Current LiabilitesMDM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

MDM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1824.07%.
Looking at the last year, MDM shows a very strong growth in Revenue. The Revenue has grown by 32.80%.
The Revenue has been decreasing by -4.00% on average over the past years.
EPS 1Y (TTM)-1824.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1683.69%
Revenue 1Y (TTM)32.8%
Revenue growth 3Y-8.7%
Revenue growth 5Y-4%
Sales Q2Q%72.78%

3.2 Future

Based on estimates for the next years, MDM will show a very strong growth in Earnings Per Share. The EPS will grow by 27.67% on average per year.
The Revenue is expected to decrease by -0.13% on average over the next years.
EPS Next Y6.31%
EPS Next 2Y35.9%
EPS Next 3Y27.67%
EPS Next 5YN/A
Revenue Next Year-5.41%
Revenue Next 2Y-1.39%
Revenue Next 3Y-0.13%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MDM.PA Yearly Revenue VS EstimatesMDM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
MDM.PA Yearly EPS VS EstimatesMDM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MDM. In the last year negative earnings were reported.
Also next year MDM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDM.PA Price Earnings VS Forward Price EarningsMDM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MDM is valued a bit cheaper than 68.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MDM is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.76
EV/EBITDA 5.84
MDM.PA Per share dataMDM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as MDM's earnings are expected to grow with 27.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.9%
EPS Next 3Y27.67%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MDM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAISONS DU MONDE SA

EPA:MDM (4/29/2025, 7:00:00 PM)

2.765

-0.07 (-2.64%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-11 2025-03-11/amc
Earnings (Next)05-15 2025-05-15
Inst Owners47.91%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap108.36M
Analysts50.91
Price Target3.93 (42.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.06
Dividend Growth(5Y)-33.92%
DP-1.65%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.1%
PT rev (3m)-31.98%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-38.67%
EPS NY rev (3m)-267.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-5.5%
Revenue NY rev (3m)-11.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF 0.76
P/OCF 0.65
P/B 0.22
P/tB 21.25
EV/EBITDA 5.84
EPS(TTM)-3.62
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)3.64
FCFY131.69%
OCF(TTM)4.23
OCFY152.92%
SpS39.19
BVpS12.75
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.12%
ROE -27.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.8%
FCFM 9.29%
ROA(3y)-1.72%
ROA(5y)-0.18%
ROE(3y)-5.32%
ROE(5y)-0.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.25%
F-Score5
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 4.88
Debt/EBITDA 3.89
Cap/Depr 10.13%
Cap/Sales 1.5%
Interest Coverage N/A
Cash Conversion 138.28%
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.32
Altman-Z N/A
F-Score5
WACC3.61%
ROIC/WACCN/A
Cap/Depr(3y)24.05%
Cap/Depr(5y)25.74%
Cap/Sales(3y)3.48%
Cap/Sales(5y)3.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1824.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1683.69%
EPS Next Y6.31%
EPS Next 2Y35.9%
EPS Next 3Y27.67%
EPS Next 5YN/A
Revenue 1Y (TTM)32.8%
Revenue growth 3Y-8.7%
Revenue growth 5Y-4%
Sales Q2Q%72.78%
Revenue Next Year-5.41%
Revenue Next 2Y-1.39%
Revenue Next 3Y-0.13%
Revenue Next 5YN/A
EBIT growth 1Y-374.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6503.36%
EBIT Next 3Y332.81%
EBIT Next 5YN/A
FCF growth 1Y-7.74%
FCF growth 3Y-11.59%
FCF growth 5Y-6.1%
OCF growth 1Y-12.2%
OCF growth 3Y-13.8%
OCF growth 5Y-8.3%